Welch Allyn to acquire Protocol Systems for $145 million
This article was originally published in Clinica
Welch Allyn is to expand its patient monitoring business with the acquisition of Protocol Systems in a deal estimated at around $145 million. Privately held Welch Allyn is offering $16 per share in cash, representing a 22% premium on Protocol's share price of $13.15 last Wednesday, the day before the announcement. Protocol's shares rose to $15.70 on news of the deal.